HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

S Eastham Selected Research

gp100(280-288) melanoma antigen peptide

10/2001Phase I trial of a melanoma vaccine with gp100(280-288) peptide and tetanus helper peptide in adjuvant: immunologic and clinical outcomes.
6/2001Evaluation of peptide vaccine immunogenicity in draining lymph nodes and peripheral blood of melanoma patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


S Eastham Research Topics

Disease

2Melanoma (Melanoma, Malignant)
10/2001 - 06/2001
1Neoplasm Metastasis (Metastasis)
10/2001
1Tetanus
10/2001
1Neoplasms (Cancer)
06/2001

Drug/Important Bio-Agent (IBA)

2Monatide (IMS 3015)IBA
10/2001 - 06/2001
2gp100(280-288) melanoma antigen peptideIBA
10/2001 - 06/2001
2Peptides (Polypeptides)IBA
10/2001 - 06/2001
2VaccinesIBA
10/2001 - 06/2001
1CytokinesIBA
10/2001
1saponin QA-21V1 (QS21)IBA
10/2001
1Immunologic Adjuvants (Immunologic Adjuvant)IBA
10/2001
1EpitopesIBA
10/2001
1Tetanus Toxoid (Vaccine, Tetanus)FDA Link
10/2001
1Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA
06/2001
1gp100(17-25) peptideIBA
06/2001
1Monophenol Monooxygenase (Tyrosinase)IBA
06/2001
1Protein Subunit VaccinesIBA
06/2001
1HLA-A1 Antigen (HLA A1 Antigen)IBA
06/2001
1HLA-A2 Antigen (HLA A2 Antigen)IBA
06/2001
1HLA-A3 Antigen (HLA A3 Antigen)IBA
06/2001
1EmulsionsIBA
06/2001